Formulation of transdermal testosterone Treatment method

摘要

Claim 1: a transdermal formulation or through mucosa comprising: 2% Weight of testosterone, alkanol c2-4 polyols, and monoalquilo ether, Diethylene glycol, wherein the formulation is substantially free of long-chain Fatty alcohols, Fatty Acids Long Chain and Long Chain Fatty Esters.Claim: a 20 transdermal formulation or through mucosa comprising: 2% Weight of testosterone, 44.0% Weight of 20.0 wt% of ethanol, Propylene Glycol, 5.0% Weight of monoetilo ether of Diethylene glycol, 1.20% Weight of carbomer, 0.35 wt% triethanolamine, 0.06% Weight of disodium edetate and Water where the above formulation is substantially free of long-chain Fatty alcohols, esters of Long Chain fatty acids and Long Chain Fatty.Claim 22: a formulation of any of claims 1 to 21, where the formulation is in the form of a gel, Cream, Lotion, Ointment, spray, aerosol, emulsion, suspension, Liposomes, Lacquer, Patch, bandage, sublingual tablet, buccal tablet, S Upositorio, dosage form, vaginal or Occlusive Dressing.